IMUNON Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus

Media Type
Article
Publish or Event Date
Research Institution
IMUNON, Inc.
Short Title
IMUNON Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus
Content Coordinator